[Federal Register Volume 82, Number 171 (Wednesday, September 6, 2017)]
[Notices]
[Pages 42225-42226]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18827]


-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

National Highway Traffic Safety Administration

[U.S. DOT Docket No. NHTSA-2017-0057]


Reports, Forms, and Record Keeping Requirements

AGENCY: National Highway Traffic Safety Administration, DOT.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the Paperwork Reduction Act of 1995, this 
notice announces that the Information Collection Request (ICR) 
abstracted below will be submitted to the Office of Management and 
Budget (OMB) for review. The ICR describes the nature of the 
information collection and its expected burden.

DATES: Comments must be received on or before November 6, 2017.

ADDRESSES: You may submit comments identified by DOT Docket ID Number 
NHTSA-2017-0057 using any of the following methods:
    Electronic submissions: Go to http://www.regulations.gov and follow 
the on-line instructions for submitting comments.
    Mail, Hand Delivery, or Courier: U.S. Department of Transportation, 
1200 New Jersey Avenue SE., Docket Management Facility, M-30, Room W12-
140, Washington, DC 20590.
    Docket hours are 9 a.m. to 5 p.m., Monday through Friday, except 
Federal holidays; phone 202-647-5527.

FOR FURTHER INFORMATION CONTACT: Ms. Amy Berning, Contracting Officer's 
Representative, Office of Behavioral Safety Research, National Highway 
Traffic Safety Administration, 1200 New Jersey Avenue SE., Washington, 
DC 20590. Ms. Berning's phone number is 202-366-5587 and the email 
address is [email protected].

SUPPLEMENTARY INFORMATION: 
    OMB Control Number: None.
    Title: Drug Use by Drivers Arrested for Driving Under the Influence 
or Driving While Under the Influence of Drugs
    Form Number: This collection of information uses no standard forms.
    Type of Request: Regular.
    Respondents--Under this proposed effort, NHTSA will collect data 
from approximately 1,000 drivers/participants.
    Estimated time per Participant--NHTSA estimates that participants 
will spend an average of 15 minutes to complete the survey and provide 
the oral fluid specimen. The respondents would not incur any reporting 
cost or record keeping burden from the data collection.
    Total Estimated Annual Burden Hours: 250 hours per year.
    Frequency of Collection: Each participant will provide one oral 
fluid sample and respond to the survey questions only once during the 
study period.
    Summary of Collection of Information: This study will estimate the 
prevalence of drugs in drivers arrested for impaired driving. The goal 
is to better understand the frequency of alcohol, prescription, over-
the-counter, and illicit drugs, in impaired driving arrests.
    A minimum of 1,000 drivers arrested for impaired driving, who 
consent to voluntarily participate, will provide an oral fluid sample 
and respond to interview questions. The oral fluid sample provides 
information on the participant's use of 50 or more drug(s). Trained 
researchers will ask

[[Page 42226]]

participants questions regarding demographics, driving, alcohol, and 
drug use.
    Data collection would take place over a six month period at two to 
three sites across the country. The research team will coordinate with 
the local police departments and officials at these sites. There will 
be a private room at each police department's booking facility for this 
study's use.
    A police officer will briefly inform the driver/potential 
participant of the opportunity to participate in a research study 
sponsored by NHTSA. If the driver is interested, a researcher will 
provide full information about the study. If the driver is not 
interested, no information will be collected on that person. The 
researcher will highlight that participation is voluntary, the oral 
fluid and survey responses will be anonymous, and the participant may 
stop the study at any time. The results of the drug test and 
questionnaire will not be provided to anyone outside of the research 
team (including to the participant), and participation in the study 
will not be used to help or hurt the individual in any related legal 
proceedings. All participants must be 18 years of age or older to 
participate.
    To provide an oral fluid sample, a participant simply places a 
cotton swab in their mouth for approximately 5 minutes. The specimen 
will be sent to an independent laboratory for analyses. The participant 
will also be provided a self-report survey on alcohol and drug use, 
perceptions of impaired driving, and driving behaviors. This survey 
will take approximately 10 minutes and will be conducted via an 
electronic tablet or, if needed, a paper copy will be available. All 
data will be housed on a secure data collection and management site. No 
identifying participant information will be collected or used in the 
study. Drug test results will only be associated with survey responses 
using a project subject code.
    Description of the Need for the Information and Proposed Use of the 
Information: The purpose of this study is to examine the drug presence 
and drug use characteristics of drivers arrested for impaired driving. 
While there is extensive research on alcohol-impaired driving, 
significantly less is known about the prevalence and risk factors of 
over-the-counter, prescription, and illegal drug-positive driving. A 
significant reason for this lack of information is that impaired 
drivers with alcohol in their system are rarely tested for other drugs 
and, when tested, are only tested for a few drugs. To address this 
knowledge gap, this study will obtain a biological specimen from the 
drivers, to directly learn about drug use, along with collecting self-
report data.
    The data will be used to better understand the prevalence of a 
variety of drugs in impaired drivers and better understand risk factors 
for drug-impaired driving.

    Authority: 44 U.S.C. Section 3506(c)(2)(A).

    Issued in Washington, DC.
Jeff Michael,
Associate Administrator, Research and Program Development.
[FR Doc. 2017-18827 Filed 9-5-17; 8:45 am]
 BILLING CODE 4910-59-P